Home Casteddu.com FAQ My Amedeo About Flying Publisher   

The Medical Article of the Year 2008:
Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78.
Free full-text


  Ovarian Neoplasms

 

Free Subscription


11.06.2008

1 BMC Cancer
2 Br J Cancer
3 Cancer
2 Cancer Lett
1 Cancer Res
3 Clin Cancer Res
10 Gynecol Oncol
1 Tumour Biol


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMC Cancer

  1. EVANS DG , Shenton A, Woodward E, Lalloo F, et al
    Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: risks of breast/ovarian cancer quoted should reflect the cancer burden in the family.
    BMC Cancer. 2008;8:155.
    PubMed     Related articles    Abstract available   Free Full Text


    Br J Cancer

  2. ANTONIOU AC , Cunningham AP, Peto J, Evans DG, et al
    The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions.
    Br J Cancer. 2008;.
    PubMed     Related articles    Abstract available

  3. AHMED N , Riley C, Quinn MA
    An immunohistochemical perspective of PPARbeta and one of its putative targets PDK1 in normal ovaries, benign and malignant ovarian tumours.
    Br J Cancer. 2008;.
    PubMed     Related articles    Abstract available


    Cancer

  4. HUANG L , Cronin KA, Johnson KA, Mariotto AB, et al
    Improved survival time: What can survival cure models tell us about population-based survival improvements in late-stage colorectal, ovarian, and testicular cancer?
    Cancer. 2008;.
    PubMed     Related articles    Abstract available

  5. CIBULL ML , Karabakhtsian RG
    Editorial. Endometrioid epithelial ovarian cancer.
    Cancer. 2008;112:2108-11.
    PubMed     Related articles   

  6. AZAD NS , Annunziata CM, Steinberg SM, Minasian L, et al
    Lack of reliability of CA125 response criteria with anti-VEGF molecularly targeted therapy.
    Cancer. 2008;112:1726-32.
    PubMed     Related articles    Abstract available


    Cancer Lett

  7. RIGHETTI SC , Perego P, Carenini N, Zunino F, et al
    Cooperation between p53 and p73 in cisplatin-induced apoptosis in ovarian carcinoma cells.
    Cancer Lett. 2008;.
    PubMed     Related articles    Abstract available

  8. TANG B , Yang Z, Huang J, Hao Z, et al
    Evaluation of human major histocompatibility complex class I chain-related A as a potential target for tumor imaging.
    Cancer Lett. 2008;263:99-106.
    PubMed     Related articles    Abstract available


    Cancer Res

  9. ZHANG S , Balch C, Chan MW, Lai HC, et al
    Identification and characterization of ovarian cancer-initiating cells from primary human tumors.
    Cancer Res. 2008;68:4311-20.
    PubMed     Related articles    Abstract available


    Clin Cancer Res

  10. BANZATO A , Bobisse S, Rondina M, Renier D, et al
    A Paclitaxel-Hyaluronan Bioconjugate Targeting Ovarian Cancer Affords a Potent In vivo Therapeutic Activity.
    Clin Cancer Res. 2008;14:3598-606.
    PubMed     Related articles    Abstract available

  11. TSURUTA Y , Pereboeva L, Breidenbach M, Rein DT, et al
    A fiber-modified mesothelin promoter-based conditionally replicating adenovirus for treatment of ovarian cancer.
    Clin Cancer Res. 2008;14:3582-8.
    PubMed     Related articles    Abstract available

  12. WOLOSZYNSKA-READ A , Mhawech-Fauceglia P, Yu J, Odunsi K, et al
    Intertumor and Intratumor NY-ESO-1 Expression Heterogeneity Is Associated with Promoter-Specific and Global DNA Methylation Status in Ovarian Cancer.
    Clin Cancer Res. 2008;14:3283-90.
    PubMed     Related articles    Abstract available


    Gynecol Oncol

  13. DEVINE KM , Smicun Y, Hope JM, Fishman DA, et al
    S1P induced changes in epithelial ovarian cancer proteolysis, invasion, and attachment are mediated by Gi and Rac.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available

  14. BOYD J
    Whence epithelial ovarian carcinoma?
    Gynecol Oncol. 2008;109:161-3.
    PubMed     Related articles   

  15. DOWDY SC , Loewen RT, Aletti G, Feitoza SS, et al
    Assessment of outcomes and morbidity following diaphragmatic peritonectomy for women with ovarian carcinoma.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available

  16. BOUCHARDY C , Fernandez S, Merglen A, Usel M, et al
    Increased risk of second cancer among patients with ovarian borderline tumors.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available

  17. LI AJ , Scoles DR, Armstrong KU, Karlan BY, et al
    Androgen receptor cytosine-adenine-guanine repeat polymorphisms modulate EGFR signaling in epithelial ovarian carcinomas.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available

  18. LITKOUHI B , Litkouhi B, Fleming E, Welch WR, et al
    Overexpression of CEACAM6 in borderline and invasive mucinous ovarian neoplasms.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available

  19. RIEDINGER JM , Eche N, Basuyau JP, Dalifard I, et al
    Prognostic value of serum CA 125 bi-exponential decrease during first line paclitaxel/platinum chemotherapy: a French multicentric study.
    Gynecol Oncol. 2008;109:194-8.
    PubMed     Related articles    Abstract available

  20. ALBERTS DS , Marth C, Alvarez RD, Johnson G, et al
    Randomized phase 3 trial of interferon gamma-1b plus standard carboplatin/paclitaxel versus carboplatin/paclitaxel alone for first-line treatment of advanced ovarian and primary peritoneal carcinomas: Results from a prospectively designed analysis of pro
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available

  21. KONECNY GE , Agarwal R, Keeney GA, Winterhoff B, et al
    Claudin-3 and claudin-4 expression in serous papillary, clear-cell, and endometrioid endometrial cancer.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available

  22. MODESITT SC , Sill M, Hoffman JS, Bender DP, et al
    A phase II study of vorinostat in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: A Gynecologic Oncology Group study.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available


    Tumour Biol

  23. SALONEN J , Leminen A, Stenman UH, Butzow R, et al
    Tissue AP-2gamma and Oct-3/4, and serum CA 125 as diagnostic and prognostic markers of malignant ovarian germ cell tumors.
    Tumour Biol. 2008;29:50-6.
    PubMed     Related articles    Abstract available


Thank you for your interest in scientific medicine.


Amedeo is a Bernd Sebastian Kamps website.

   Design: